drugset / Trial / NCT01242202
A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate long-term safety and efficacy after concomitant administration of ASP1941 and α-glucosidase inhibitor in Japanese patients with type 2 diabetes mellitus.
Timeline
- Start
- 2010-10-21
- Primary completion
- 2012-05-25
- Completion
- 2012-05-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ipragliflozin | Small molecule | — | Oral |
| Background | Acarbose | Unknown | — | Oral |
| Background | Miglitol | Small molecule | — | Oral |
| Background | Voglibose | Small molecule | — | Oral |